San Francisco, California, January 31, 2018: In a recent market research report, TMR Research presents an assessment of the growth dynamics and the key factors affecting the overall pace of development of the global market for next generation sequencing. The report is titled “Next-Generation Sequencing (NGS) Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017–2025.”
Next generation sequencing has become a highly valuable tool for assembling a large number of short DNA and RNA chains using high-throughput sequencing, providing a set of much richer and more complete data than is possible with the conventional Sanger sequencing. The introduction of advanced and next generation sequencing in the recent years has thus proved to be highly resourceful and has helped open up a vast set of opportunities in the field of biotechnology. Solutions provided by the global next generation sequencing market are helping the biotechnology and life sciences sectors gain access to speedy, flexible, and high throughput sequencing options at low costs as compared to conventional sequencing.
The report presents an overview of the key factors that could influence the market significantly over the next few years, including growth drivers, challenges, trends, and regulatory scenario, an assessment of the competitive landscape of the market, and an overview of the market’s future growth prospects. The report also segments the market into careful sections so as to provide a much detailed and to the point assessment.
The report states that the rising set of applications of next generation sequencing is one of the primary drivers to influence the market massively. The market is also expected to benefit from the increased adoption of next generation sequencing across the rising number of research laboratories and the vast rise in research activities across academic institutes.
From a geographical standpoint, the market in North America presently dominates the global next generation sequencing market in terms of market share in value. The region is expected to continue to show a high demand for next generation sequencing, but is likely to lose market share to Asia Pacific.
The market in Asia Pacific is expected to display a high growth rate in the global next generation sequencing market due to improved healthcare initiatives, vastly increased capital investments, and the growing adoption of current innovative models by pharmaceutical and biotechnology players. A massive chunk of the global next generation sequencing market continues to be taken up by a collective base of end users from government research institutions, academic organizations, and biopharmaceutical companies operating in the region.
The competitive landscape of the global next generation sequencing market is also examined at great depths in the report. While the market is presently consolidated, with a small number of companies operating in it owing to the complex technologies and high cost required to develop effective products, the scenario is expected to change in the next few years as a number of new companies have started making inroads into this market. This will make the market more competitive as compared to present times and will lead to an encouraging rise in the development of new systems and increased availability across several regional markets.
Some of the leading companies operating in the market profiled in the report are Perkinelmer, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Gatc Biotech AG, Illumina, Inc., Qiagen N.V., Agilent Technologies, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Thermo Fisher Scientific Inc., Macrogen, Inc., and Oxford Nanopore Technologies, Ltd.
Get Sample Copy of this Report